Tompkins Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-99
Closed -$4.8K 660
2025
Q4
$4.8K Hold
99
﹤0.01% 488
2025
Q3
$4.67K Hold
99
﹤0.01% 478
2025
Q2
$4.78K Hold
99
﹤0.01% 475
2025
Q1
$5.49K Buy
+99
New +$5.36K ﹤0.01% 483
2024
Q4
Sell
-178
Closed -$10.3K 588
2024
Q3
$10.3K Buy
+178
New +$9.61K ﹤0.01% 472
2020
Q2
Sell
-365
Closed -$16K 418
2020
Q1
$16K Sell
365
-259
-42% -$12.4K ﹤0.01% 292
2019
Q4
$31K Buy
+624
New +$29.2K 0.01% 287
2017
Q3
Sell
-300
Closed -$14K 425
2017
Q2
$14K Buy
+300
New +$14.3K ﹤0.01% 302
2013
Q3
Sell
-300
Closed -$15K 489
2013
Q2
$15K Buy
+300
New +$16K ﹤0.01% 378

Other funds holding SNY

Tompkins Financial's SNY Position: Q1 2026 in Review

Tompkins Financial sold out of Sanofi (SNY) in Q1 2026, closing a stake of 99 shares — an estimated $4.8K sold.

Tompkins Financial first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $31K in Q4 2019. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Tompkins Financial reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Tompkins Financial sold 99 Sanofi shares in Q1 2026, an estimated $4.8K.
  • Tompkins Financial first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
  • Tompkins Financial's Sanofi position peaked at $31K in Q4 2019.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Tompkins Financial's 13F filing for Q1 2026, filed 9 Apr 2026.